Press release
Anticoagulants Market Size to Reach US$ 67.0 Billion, Globally, by 2028 at 10.1% CAGR
Anticoagulants Market Research & Forecast Report 2023-2028
Report Highlights
How big is the anticoagulants market?
According to the report, The global anticoagulants market size reached US$ 37.4 Billion in 2022 Looking forward, IMARC Group expects the market to reach US$ 67.0 Billion by 2028, exhibiting a growth rate (CAGR) of 10.1% during 2023-2028.
What is anticoagulants?
Anticoagulants are specialized medicines that prevent blood clots and reduce the chances of developing severe medical conditions, such as strokes and heart attacks. They include warfarin, apixaban (eliquis), dabigatran (pradaxa), edoxaban (lixiana), and rivaroxaban (xarelto). They are widely used in the treatment of transient ischaemic attacks, atrial fibrillation and heart attacks, deep vein thrombosis (DVT), stroke, and pulmonary embolisms (PE). They aid in thinning blood and preventing blood cells called platelets from clumping together to form a clot and prolonging the clotting time. They come in different strengths and colors and are usually available in oral, such as tablets and capsules, and injectable forms. At present, anticoagulants are readily available at online stores, hospitals, and retail pharmacies across the globe.
Get a PDF Sample for more detailed market insights: https://www.imarcgroup.com/anticoagulants-market/requestsample
What are the growth prospects and trends in the anticoagulants industry?
The growing geriatric population and the increasing prevalence of cardiovascular disorders across the globe represent one of the key factors positively influencing the market. In addition, rising cases of pulmonary embolism (PE) on account of sedentary lifestyles and hectic work schedules are increasing the risk of heart-related diseases worldwide. This, along with the extended sitting, smoking, trauma, blood disorders, and autoimmune diseases can cause blood clotting in different parts of the body, which is catalyzing the demand for anticoagulants. The increasing prevalence of human immunodeficiency virus (HIV), Lyme disease, obesity, hepatitis C, and chronic inflammation are creating a favorable market outlook. Moreover, the increasing awareness about weight management and maintaining cardiovascular health among individuals and the importance of blood thinning is bolstering the market growth. Additionally, the easy availability of anticoagulants across offline and online distribution channels, coupled with the facilities of free doorstep delivery, lucrative deals and discounts, and secured payment gateways, are propelling the market growth. Besides this, the introduction of new anticoagulant agents that are orally administered and need less laboratory monitoring is contributing to the market growth. Furthermore, increasing investments by leading market players in research and development (R&D) activities for quality improvement of anticoagulants are creating a positive market outlook. Furthermore, favorable initiatives by non-profitable organizations (NPOs) to promote awareness about cardiovascular health are strengthening the growth of the market. Moreover, the growing partnerships between public health agencies and governments of various countries to prevent heart disease and strokes are catalyzing the demand for anticoagulants. Apart from this, the integration of advanced technologies, such as artificial intelligence (AI) on mobile devices for medication adherence in stroke patients undergoing anticoagulation therapy, is anticipated to drive the market.
What is included in market segmentation?
The report has segmented the market into the following categories:
Breakup by Drug Class:
Novel Oral Anticoagulants (NOACs)
Heparin and Low Molecular Weight Heparin (LMWH)
Vitamin K Antagonist
Others
Breakup by Route of Administration:
Oral Anticoagulant
Injectable Anticoagulant
Breakup by Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Stores
Others
Breakup by Application:
Atrial Fibrillation and Heart Attack
Stroke
Deep Vein Thrombosis (DVT)
Pulmonary Embolism (PE)
Others
Breakup by Region:
North America
Asia-Pacific
Europe
Latin America
Middle East and Africa
Who are the key players operating in the industry?
The report covers the major market players including:
Alexion Pharmaceuticals Inc
Aspen Holdings
Bayer AG
Boehringer Ingelheim International GmbH
Bristol-Myers Squibb Company
Daiichi Sankyo Company Limited
Reddy's Laboratories Ltd
GlaxoSmithKline plc
Johnson & Johnson Private Limited
Pfizer Inc.
Ask Customization and Browse full report with TOC & List of Figure: https://www.imarcgroup.com/anticoagulants-market
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
Browse Top Trending Market Reports:
https://www.openpr.com/news/3032268/onychomycosis-treatment-market-size-to-reach-us-4-3-billion
https://www.openpr.com/news/3032302/logistics-market-size-in-uk-2023-28-share-growth-and-industry
https://www.openpr.com/news/3032289/united-states-biofertilizer-market-size-to-reach-us-1-240
https://www.openpr.com/news/3032314/soft-skills-training-market-size-in-gcc-to-hit-us-1-059-million
https://www.openpr.com/news/3036711/polyphenylene-sulfide-pps-market-size-to-reach-us-2-4-billion
Contact us:
IMARC Group
Email: sales@imarcgroup.com
USA: +1-631-791-1145 | Asia: +91-120-433-0800
Address: 134 N 4th St. Brooklyn, NY 11249, USA
Website: https://www.imarcgroup.com/
Follow us on Twitter: @imarcglobal
Linkedin: https://www.linkedin.com/company/imarc-group
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.
Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Anticoagulants Market Size to Reach US$ 67.0 Billion, Globally, by 2028 at 10.1% CAGR here
News-ID: 3040706 • Views: …
More Releases from IMARC Group
Global Cellulose Prices Q2 2025 - Trend, News & Insights
North America Cellulose Prices Movement Q2
Cellulose Prices in United States:
In Q2 2025, US Cellulose Prices were pressured by reduced output at pulp mills due to maintenance and labor shortages. Timber harvesting delays from adverse weather constrained raw material supply. Steady demand from packaging and construction supported consumption, while rising fuel surcharges and logistics costs added to overall pricing challenges.
Get the Real-Time Prices Analysis: https://www.imarcgroup.com/cellulose-pricing-report/requestsample
APAC Cellulose Prices Movement Q2:
Cellulose Prices in…
E-Waste Manufacturing Plant Report 2025: Raw Materials Requirement, Setup Cost a …
E-Waste refers to discarded electronic devices such as computers, smartphones, televisions, and household appliances that have reached the end of their life cycle. It contains both valuable materials like gold, copper, and rare earth elements, as well as hazardous substances such as lead, mercury, and cadmium, making proper recycling crucial for environmental safety and resource recovery.
Setting up an e-waste recycling plant requires investment in land, machinery for dismantling and extraction,…
Cement Bricks Manufacturing Plant Report 2025: Business Plan, and Setup Details
Cement bricks are solid or hollow rectangular blocks made from a mixture of cement, sand, and aggregates, molded and cured for strength and durability. They are widely used in construction due to their uniform shape, load-bearing capacity, resistance to fire and weather, and cost-effectiveness compared to traditional clay bricks.
Setting up a cement bricks manufacturing plant involves securing land, installing machinery like mixers and molding units, sourcing raw materials, and employing…
Propyl Cyanoacetate Production Cost Report 2025: Detailed Guide on Plant Setup, …
Setting up a propyl cyanoacetate production facility necessitates a detailed market analysis alongside granular insights into various operational aspects, including unit processes, raw material procurement, utility provisions, infrastructure setup, machinery and technology specifications, workforce planning, logistics, and financial considerations.
IMARC Group's report titled "Propyl Cyanoacetate Production Cost Analysis Report 2025: Industry Trends, Plant Setup, Machinery, Raw Materials, Investment Opportunities, Cost and Revenue" offers a comprehensive guide for establishing a propyl cyanoacetate…
More Releases for Anticoagulant
Peptide Anticoagulant Drugs Market Massive Growth opportunity Ahead
Peptide Anticoagulant Drugs market Size, Status, and Forecast for the 2025-2034. In-depth research has been compiled to provide the most up-to-date information on key aspects of the worldwide market. This research report covers major aspects of the Peptide Anticoagulant Drugs Market including drivers, restraints, historical and current trends, regulatory scenarios, and technological advancements. It provides the industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply…
Anticoagulant Rodenticides Market Is Expanding So Quickly
USD Analytics Market recently introduced Global Anticoagulant Rodenticides Market study with 65+ pages in-depth overview, describing about the Product / Industry Scope and elaborates market outlook and status (2024-2032). The market Study is segmented by key regions which is accelerating the marketization. At present, the market is developing its presence and some of the key players from the complete study are BASF, Bayer, Syngenta, Rentokil, LiphaTech, JT Eaton, Bell Laboratories,…
Anticoagulant Reversal Drugs Market In-Depth Analysis 2029
Fairfield Market Research offers a complete understanding of the Global Anticoagulant Reversal Drugs Market in its latest research report. The report includes an unbiased analysis of the market dynamics. The report covers growth prospects, market development potential, product profitability, supply and demand curves and predictions, and government policies.
The report has been put together using reliable tools to assess the primary and secondary data. The data is represented in the…
Anticoagulant Treatment Market 2021 | Detailed Report
The Anticoagulant Treatment market research report delivers accurate data and innovative corporate analysis, helping organizations of all sizes make appropriate decisions. The Anticoagulant Treatment report also incorporates the current and future global market outlook in the emerging and developed markets. Moreover, the report also investigates regions/countries expected to witness the fastest growth rates during the forecast period.
Download FREE Sample Report @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=4988667
The Anticoagulant Treatment research report also provides…
Anticoagulants Market To See Record Break Revenue $43.42 Million By 2025 | Vitam …
Anticoagulants are medicinal substances that reduce the coagulation of blood and prolong the clotting time. Anticoagulant drugs achieve their effects by suppressing the synthesis or function of various clotting factors that exist in the blood. The global anticoagulants market is anticipated to show significant market growth during the forecast period, owing to increase in prevalence of ischemic heart disease and venous thromboembolism (VTE) and awareness of novel oral anticoagulants (NOACs).…
Anticoagulant Drugs Market Size, Share, Development by 2023
New report published by Market Research Report Store (MRRS) which offers insights on the global Anticoagulant Drugs market.
Click to view the full report TOC, figure and tables:
https://www.marketresearchreportstore.com/reports/241687/global-anticoagulant-drugs-market
Global Anticoagulant Drugs Market: Forecast by Type / Application / Region
Anticoagulant drugs (also known as blood thinners) are chemical substances that prevent or reduce coagulation of blood and prolong the blood clotting time.
According to this study, over the next five years the Anticoagulant Drugs…
